In a study including 231 Caucasian patients, Schürks et al. (2007) demonstrated that a polymorphism in the gene encoding the G protein beta3 subunit (GNB3 C825T) is significantly associated with triptan treatment outcome in cluster headache (Gentile et al., 2010) (Table 3). Here, GNB3 is linked to Cluster headache.